Point-of-care program in HIV, tuberculosis, and associated conditions: A virtual global technical assistance platform to strengthen HIV and tuberculosis workforce capacity.
Journal
Journal of clinical tuberculosis and other mycobacterial diseases
ISSN: 2405-5794
Titre abrégé: J Clin Tuberc Other Mycobact Dis
Pays: England
ID NLM: 101682877
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
entrez:
17
5
2021
pubmed:
18
5
2021
medline:
18
5
2021
Statut:
epublish
Résumé
A global multi-disciplinary faculty was established to work collaboratively and provide virtual technical assistance, using a point-of-care continuing education model, to clinicians across the world engaged in the care of patients with either HIV infection or tuberculosis. Ancillary offerings included live or virtual lectures, case-based conferences, and courses. In spite of the considerable disruption of the program due to the COVID-19 pandemic, we engaged and assisted a substantial number of clinicians across the world and provided meaningful contributions to their continuous professional development and patient care. In light of the ongoing pandemic, virtual technical assistance models such as this should be scaled to continue essential high-quality HIV/TB services.
Identifiants
pubmed: 33997312
doi: 10.1016/j.jctube.2021.100238
pii: S2405-5794(21)00027-9
pmc: PMC8102617
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100238Informations de copyright
© 2021 The Authors. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Pulmonology. 2018 Mar - Apr;24(2):132-141
pubmed: 29229274
Science. 2020 Jul 24;369(6502):366-368
pubmed: 32703860
Hum Resour Health. 2005 Feb 24;3(1):2
pubmed: 15730555
Front Public Health. 2019 Aug 13;7:222
pubmed: 31457000
Hum Resour Health. 2006 Aug 24;4:23
pubmed: 16930480
JMIR Med Educ. 2020 Apr 20;6(1):e16777
pubmed: 32310137
Clin Infect Dis. 2021 May 4;72(9):1615-1622
pubmed: 32211757
Acad Med. 2007 Feb;82(2):154-60
pubmed: 17264693
Int J Tuberc Lung Dis. 2020 Nov 1;24(11):1215-1216
pubmed: 33172532
J Thorac Dis. 2015 Jul;7(7):1080-5
pubmed: 26380718
Epidemiol Infect. 2020 Aug 24;148:e185
pubmed: 32829742
Postgrad Med J. 2015 Feb;91(1072):83-91
pubmed: 25655251
J Clin Tuberc Other Mycobact Dis. 2018 Apr 11;11:23-27
pubmed: 31720388
J Clin Tuberc Other Mycobact Dis. 2019 Jul 02;17:100114
pubmed: 31788557
Emerg Infect Dis. 2020 Nov;26(11):2709-2712
pubmed: 32917293
AIDS Behav. 2020 Nov;24(11):3006-3009
pubmed: 32451939
Pulmonology. 2021 Jan-Feb;27(1):67-69
pubmed: 32561353
J Int AIDS Soc. 2019 May;22(5):e25286
pubmed: 31111684
Lancet HIV. 2020 May;7(5):e308-e309
pubmed: 32272084
Lancet HIV. 2020 Jun;7(6):e384-e385
pubmed: 32359421
AIDS Res Ther. 2020 Oct 4;17(1):59
pubmed: 33012282
Int J Tuberc Lung Dis. 2012 Jul;16(7):950-4
pubmed: 22564252
AIDS Behav. 2020 Jul;24(7):2024-2032
pubmed: 32350773
AIDS. 2020 Dec 1;34(15):2328-2331
pubmed: 32910069
AIDS Behav. 2020 Oct;24(10):2770-2772
pubmed: 32382823
Clin Infect Dis. 2016 Oct 1;63(7):966-975
pubmed: 27358352
Ann Ist Super Sanita. 2018 Jan-Mar;54(1):58-60
pubmed: 29616675
Lancet HIV. 2020 Sep;7(9):e629-e640
pubmed: 32771089